Abstract
In the past decade, Chinese vaccine market tripled in scale. China has already
become the world' s largest vaccine producer and now has 28 vaccine companies,
ranking NO.1 around the globe. It can produce one billion person-portions
annually, besides, varieties and quantity also ranks the top in the world.
Output of common vaccine reaches 500 million person-portions such as HBV
vaccine, measles vaccine, etc. Fully planned immunization has been realized.
Compared to developed countries, expenses of China on vaccine and diseases
treatment are relatively low; therefore, China will attach great importance to
vaccine industry development and take it as the key of healthcare and
bio-technology industry. The Development Strategy of China Bio-technology
Industry has rendered the development of secure new types of vaccines as
priority; in the meantime, Chinese government has employed preferential
taxation policy to this industry. In consequence, vaccine industry will become
a high-tech sector with great potential in China bio-technology field. It is
forecasted that China vaccine market scale will approximate RMB8 billion in
2020, with an annual growth rate of 15%, far above world' s level 10%.
Based on authoritative statistics, this report makes in-depth analysis on
China vaccine industry development, vaccine market, vaccine import & export,
key vaccine producers, and also forecasts the development trend of China' s
vaccine industry in 2009. Vaccines involved in this report are Flu Vaccine,
HBV Vaccine, Cerebrospinal Meningitis Vaccine, HIV vaccine, A/HINI vaccine as
well as animal vaccines.
| 
View Cart
